Hemodynamic effects of lisinopril, a new angiotensin converting enzyme inhibitor. and betaxolol, a new .BETA.1-selective .BETA.-blocking agent, in essential hypertension. | Zendy

AI Assistant Blog Pricing

Hemodynamic effects of lisinopril, a new angiotensin converting enzyme inhibitor. and betaxolol, a new .BETA.1-selective .BETA.-blocking agent, in essential hypertension.

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.